Archive - February 2019
Experimental Parkinson’s therapy shows promise
FDA starts review of Biogen’s Tecfidera follow-up for MS
MHRA gives Nuformix’ NXP001 studies the go-ahead
Mental health information provided to patients improving, study finds
Cell Medica given $8.7 million to develop cancer therapy
ViiV Healthcare and Radboud team up for HIV drug targets
Senate grilling makes pharma CEOs squirm, but give little ground
FDA begins speedy review of Celgene’s Revlimid combo in lymphoma